Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome
10.1016/j.vhri.2015.07.001
Saved in:
Main Authors: | Zhao, YJ, Khoo, AL, Lin, L, Teng, M, Wu, TS, Chan, M.Y., Lim, BP |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Elsevier BV
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/206228 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Switching from Ticagrelor to Clopidogrel in Asian Patients with ST-Elevated Myocardial Infarction – A Time Dependent Analysis Study
by: Koh L, et al.
Published: (2020) -
Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based on the PLATO trial: A Singapore healthcare perspective
by: Chin, C.T., et al.
Published: (2014) -
Effect of Ticagrelor on Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction (HEALING-AMI)
by: Park, Y, et al.
Published: (2021) -
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2011) -
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2016)